Lisheng Pharmaceuticals announced that the company received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” for the drug tigrello issued by the State Drug Administration, and that this variety has passed the chemical raw material marketing application.
力生制药：替格瑞洛原料药通过上市申请
Lisheng Pharmaceuticals: Tigrello's API approved for marketing application
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.